These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 18274393)

  • 1. [Therapeutic education regarding type 1 diabetes (DM1)].
    Jansà M; Vidal M; Conget I; Giménez M; Esmatjes E; Yoldi C; Levy I
    Rev Enferm; 2007 Oct; 30(10):23-32. PubMed ID: 18274393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Systems of continuous subcutaneous insulin infusion. Therapeutic education program].
    Galindo Rubio M
    Rev Enferm; 2011 Jun; 34(6):24-30. PubMed ID: 21830364
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Benefits of continuous subcutaneous insulin infusion in type 1 diabetes previously treated with multiple daily injections with once-daily glargine and pre-meal analogues.
    Torres I; Ortego J; Valencia I; García-Palacios MV; Aguilar-Diosdado M
    Exp Clin Endocrinol Diabetes; 2009 Sep; 117(8):378-85. PubMed ID: 19629931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of a local heating device on insulin and glucose pharmacokinetic profiles in an open-label, randomized, two-period, one-way crossover study in patients with type 1 diabetes using continuous subcutaneous insulin infusion.
    Raz I; Weiss R; Yegorchikov Y; Bitton G; Nagar R; Pesach B
    Clin Ther; 2009 May; 31(5):980-7. PubMed ID: 19539098
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Type I diabetes and insulin therapy.
    Hirsch IB; Farkas-Hirsch R
    Nurs Clin North Am; 1993 Mar; 28(1):9-23. PubMed ID: 8451220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Compliance and administration methods in management of type 1 diabetes.
    Lombardo F; Salzano G; Messina MF; De Luca F
    Acta Biomed; 2005; 76 Suppl 3():66-9. PubMed ID: 16915802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intensive diabetes education program and multidisciplinary team approach in management of newly diagnosed type 1 diabetes mellitus: a greater patient benefit, experience at Siriraj Hospital.
    Likitmaskul S; Wekawanich J; Wongarn R; Chaichanwatanakul K; Kiattisakthavee P; Nimkarn S; Prayongklin S; Weerakulwattana L; Markmaitree D; Ritjarean Y; Pookpun W; Punnakanta L; Angsusingha K; Tuchinda C
    J Med Assoc Thai; 2002 Aug; 85 Suppl 2():S488-95. PubMed ID: 12403224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of Continuous Subcutaneous Insulin Infusion (CSII): parental and professional perceptions of self-care mastery and autonomy in children and adolescents.
    Weissberg-Benchell J; Goodman SS; Antisdel Lomaglio J; Zebracki K
    J Pediatr Psychol; 2007; 32(10):1196-202. PubMed ID: 17599966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of metabolic control, patient education and initiation of insulin therapy on the quality of life of patients with type 2 diabetes mellitus.
    Braun A; Sämann A; Kubiak T; Zieschang T; Kloos C; Müller UA; Oster P; Wolf G; Schiel R
    Patient Educ Couns; 2008 Oct; 73(1):50-9. PubMed ID: 18583087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Continuous subcutaneous insulin infusion (CSII) 30 years later: still the best option for insulin therapy.
    Bruttomesso D; Costa S; Baritussio A
    Diabetes Metab Res Rev; 2009 Feb; 25(2):99-111. PubMed ID: 19172576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AADE position statement: education for continuous subcutaneous insulin infusion pump users. American Association of Diabetes Educators.
    Diabetes Educ; 1997; 23(4):397-8. PubMed ID: 9305004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intuitiveness, instruction time, and patient acceptance of a prefilled insulin delivery device and a reusable insulin delivery device in a randomized, open-label, crossover handling study in patients with type 2 diabetes.
    Reimer T; Hohberg C; Pfützner AH; Jørgensen C; Jensen KH; Pfützner A
    Clin Ther; 2008 Dec; 30(12):2252-62. PubMed ID: 19167585
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin delivery systems: reducing barriers to insulin therapy and advancing diabetes mellitus treatment.
    Brunton S
    Am J Med; 2008 Jun; 121(6 Suppl):S35-41. PubMed ID: 18514089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Restoring treatment with continuous insulin infusion pump (BICI)].
    Méndez López AM
    Rev Enferm; 2008 Jun; 31(6):43-8. PubMed ID: 18724516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Evaluation after one year of portable insulin infusion pumps].
    Solal PC; Bertoglio J; Cupelli C
    Soins; 2004 Sep; (688):21-2. PubMed ID: 15515843
    [No Abstract]   [Full Text] [Related]  

  • 16. Treatment of diabetes mellitus using an external insulin pump in clinical practice.
    Jeandidier N; Riveline JP; Tubiana-Rufi N; Vambergue A; Catargi B; Melki V; Charpentier G; Guerci B
    Diabetes Metab; 2008 Sep; 34(4 Pt 2):425-38. PubMed ID: 18951117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In Type 1 diabetic patients with good glycaemic control, blood glucose variability is lower during continuous subcutaneous insulin infusion than during multiple daily injections with insulin glargine.
    Bruttomesso D; Crazzolara D; Maran A; Costa S; Dal Pos M; Girelli A; Lepore G; Aragona M; Iori E; Valentini U; Del Prato S; Tiengo A; Buhr A; Trevisan R; Baritussio A
    Diabet Med; 2008 Mar; 25(3):326-32. PubMed ID: 18307459
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Benefits of a bolus calculator in pre- and postprandial glycaemic control and meal flexibility of paediatric patients using continuous subcutaneous insulin infusion (CSII).
    Shashaj B; Busetto E; Sulli N
    Diabet Med; 2008 Sep; 25(9):1036-42. PubMed ID: 18937673
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Continuous subcutaneous insulin infusion versus multiple daily insulin injections in type 2 diabetes: a meta-analysis.
    Monami M; Lamanna C; Marchionni N; Mannucci E
    Exp Clin Endocrinol Diabetes; 2009 May; 117(5):220-2. PubMed ID: 19301231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Seeking the factors predisposing to local skin inflammatory state development in children with type 1 diabetes (T1DM) treated with continuous subcutaneous insulin infusion (CSII).
    Jarosz-Chobot P; Nowakowska M; Polanska J
    Exp Clin Endocrinol Diabetes; 2007 Mar; 115(3):179-81. PubMed ID: 17427107
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.